Clinical trials
Completed Phase 1 Glucose Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| Merck Sharp & Dohme LLC | 2 |
| Beta-Stim Ltd. | 1 |
| CRISPR Therapeutics AG | 1 |
| Eli Lilly and Company | 1 |
| Johnny Ludvigsson | 1 |
| Juan Pascual | 1 |
| University of Aarhus | 1 |
| Vanderbilt University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 14 |
| Diabetes Mellitus | 12 |
| Diabetes Mellitus, Type 2 | 10 |
| Metabolic Diseases | 9 |
| Endocrine System Diseases | 7 |
| Diabetes Mellitus, Type 1 | 2 |
| Insulin Resistance | 2 |
| Autoimmune Diseases | 1 |
| Body Weight | 1 |
| Epilepsy | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.